secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001193125-26-013061
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions CEO presents at J.P. Morgan Healthcare Conference; no new data
--------------------------------------------------------------------------------

- CEO Joe Papa presented at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
- Investor slides furnished as Exhibit 99.1 contain no specific financial results or guidance updates.
- No material business or operational changes disclosed in the filing or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/0001193125-26-013061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/d921176d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-013061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer